Open AccessInterleukin-6 inhibitors: from the therapy of immuno-inflammatory rheumatic diseases to use in COVID-19
Author(s) -
N. V. Muravyeva,
Б. С. Белов
Publication year - 2022
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2022-16-11-88-94
Subject(s) - tocilizumab , medicine , rheumatoid arthritis , rheumatology , immunology , covid-19 , inflammation , pandemic , arthritis , disease , monoclonal antibody , antibody , infectious disease (medical specialty)